Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocytic) and tamoxifen – reply
2000
Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon and tamoxifen – reply
publication
Author Information
Primary Institution: Cancer Research Campaign
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website